ResearcherJiangxi Provincial People's HospitalActive in the last 2 years
Yunyan Du
Matched on ORCID iD 0000-0002-2448-9520; OpenAlex author ID A5103272301. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 2 papers
Papers 5
- E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA. Co-author DOI 10.1038/s41419-024-06729-z↗
- Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a nutrient-poor microenvironment. Co-author DOI 10.1038/s41419-024-07048-z↗
- SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. First author DOI 10.1038/s41388-023-02843-y↗
- USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1. Co-author DOI 10.1038/s41419-021-04163-z↗
- RING-finger protein 6 enhances c-Myc-mediated Warburg effect by promoting MAD1 degradation to facilitate pancreatic cancer metastasis. Co-author PMID 34094667↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaogang Peng · 4 shared papers, 2021–2024 · strength 0.71
- Paper E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT … DOI 10.1038/s41419-024-06729-z↗
- Paper Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a n… DOI 10.1038/s41419-024-07048-z↗
- Paper USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1. DOI 10.1038/s41419-021-04163-z↗
- Leifeng Chen · 4 shared papers, 2021–2024 · strength 0.64
- Paper Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a n… DOI 10.1038/s41419-024-07048-z↗
- Paper SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. DOI 10.1038/s41388-023-02843-y↗
- Paper USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1. DOI 10.1038/s41419-021-04163-z↗
- Wenming Zhang · 2 shared papers, 2023–2024 · strength 0.37
- Paper Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a n… DOI 10.1038/s41419-024-07048-z↗
- Paper SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. DOI 10.1038/s41388-023-02843-y↗
- Rongfa Yuan · 2 shared papers, 2021–2023 · strength 0.29
- Paper SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. DOI 10.1038/s41388-023-02843-y↗
- Paper USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1. DOI 10.1038/s41419-021-04163-z↗
- Fan Zhou · 1 shared paper, 2024 · strength 0.22
- Li‐Ping Jiang · 1 shared paper, 2024 · strength 0.22
- Ben Che · 1 shared paper, 2023 · strength 0.15
- Xueqiang Deng · 1 shared paper, 2023 · strength 0.15
- Hengqing Zhu · 1 shared paper, 2021 · strength 0.13
- Yumin Qiu · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.